BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors

  Deciphera Pharmaceuticals, Inc. announced positive top-line data from the INVICTUS pivotal Phase 3 clinical study of ripretinib, a broad-spectrum KIT and PDGFRα inhibitor, in patients with fourth-line and fourth-line plus gastrointestinal stromal tumors.

  August 13, 2019

   · 

  12 min read
• Drug Development

  Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors

  Data from Phase 1 Study Supports Ongoing INTRIGUE Phase 3 Clinical Study in Patients with Second-line GIST

  August 13, 2019

   · 

  11 min read
• Business

  Imara Expands Management Team and Strengthens Expertise Across Strategic Functions as it Advances IMR-687 for Sickle Cell Disease and Beta Thalassemia

  Company has appointed VPs of Program Management, Clinical Development, Technical Operations, Quality Assurance and Development Operations

  August 13, 2019

   · 

  5 min read
• Biotech Bay

  Veeva Brings Artificial Intelligence to Drug Safety

  New Veeva Vault Safety.AI reduces manual data entry for case intake to improve efficiency and scalability in pharmacovigilance

  August 13, 2019

   · 

  4 min read
• Business

  CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica

  CytoSorbents is a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world

  August 13, 2019

   · 

  6 min read
• Drug Development

  Moleculin Announces Completion of Lymphoma Trial Enrollment

  Announced its proof of concept clinical trial to evaluate its p-STAT3 inhibitor, WP1220, for the topical treatment of Cutaneous T-Cell Lymphoma (CTCL) has reached full enrollment.

  August 13, 2019

   · 

  3 min read
• Business

  ProMIS Neurosciences Announces Second Quarter 2019 Results

  Company continues to expand its portfolio of highly selective antibodies targeting root cause of Alzheimer’s, ALS and Parkinson’s disease

  August 13, 2019

   · 

  9 min read
• Business

  BIONIK Laboratories’ Fiscal Year 2020 Q1 Financial Results Feature 57% Increase in Sales

  Financial results for its first quarter of fiscal year 2020, ended June 30, 2019.

  August 13, 2019

   · 

  10 min read
• Business

  Alnylam Pharmaceuticals and Ironwood Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam’s Givosiran in Acute Hepatic Porphyria (AHP)

  lnylam Pharmaceuticals, Inc. and Ironwood Pharmaceuticals, Inc. announced a U.S. GI disease education and promotional agreement for Alnylam’s givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 (ALAS1) for the potential treatment of AHP.

  August 13, 2019

   · 

  11 min read
• BioMidwest

  Cresco Labs Announces Listing on Frankfurt Stock Exchange

  The Company’s shares continue to be listed on the Canadian Securities Exchange under the symbol “CL” and on the OTCQX under the symbol “CRLBF.”

  August 13, 2019

   · 

  4 min read